BCRX Stock: BioCryst Climbs on Approval
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is headed up in the market this morning, and for good reason. The company announced that its ORLADEYO product has been approved for commercialization in Japan. Here’s what’s happening: Skip to What You Want to Read BioCryst Pharmaceuticals Announces ORLADEYO Approval Management Commentary Why Investors Are Excited What Analysts Think … Read more